Cognitive impairment in three subtypes of multiple sclerosis

By Denney Douglas R.  

Archives of Clinical Neuropsychology, Vol. 20, Iss. 8, 2005-12 ,pp. : 967-981

Oxford University Press

Access to resources Recommend Favorite

Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients

By Zephir H.   de Seze J.   Duhamel A.   Debouverie M.   Hautecoeur P.   Lebrun C.   Malikova I.   Pelletier J.   Senechal O.   Vermersch P.  

Journal of the Neurological Sciences, Vol. 218, Iss. 1, 2004-03 ,pp. : 73-77

Elsevier

Access to resources Recommend Favorite

Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis

By Miller Aaron E  

Neurodegenerative Disease Management, Vol. 3, Iss. 5, 2013-10 ,pp. : 467-482

Future Medicine

Access to resources Recommend Favorite

The search for a balance between short and long-term treatment outcomes in multiple sclerosis

By Baumhackl Ulf  

Journal of Neurology, Vol. 255, Iss. 1, 2008-03 ,pp. : 75-83

Springer Publishing Company

Access to resources Recommend Favorite

Deficits in Planning Time but not Performance in Patients with Multiple Sclerosis

By Denney Douglas R.   Hughes Abbey J.   Owens Emily M.   Lynch Sharon G.  

Archives of Clinical Neuropsychology, Vol. 27, Iss. 2, 2012-03 ,pp. : 148-158

Oxford University Press

Access to resources Recommend Favorite